Well: Taking Calcium May Pose Heart Risks
In a large European study, people who were taking calcium supplements had nearly a 30 percent greater risk of heart attack over four years than those who were not. (Source: NYT Health)
New Phase 3 Data for Tradjenta ® (linagliptin) Tablets
May 24, 2012 (Boehringer Ingelheim) — New Phase 3 data for Tradjenta ® (linagliptin) tablets in black or African American patients with type 2 diabetes showed significant improvement in blood sugar. First published trial of a dipeptidyl peptidase-4 (DPP-4) inhibitor specifically conducted in black or African American patients with type 2 diabetes.
read more (Source: Diabetes News from dLife.com)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div
